Nikola And Nautilus On The List Of Winners And Losers Of Friday’s US Premarket Session

(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three biggest winners today are Nikola, Citizens Financial Group, and Global X AI.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Nikola (NKLA) 0.64 5.11% 2023-06-09 07:14:58
2 Citizens Financial Group (CFG) 29.37 1.87% 2023-06-09 07:17:36
3 Global X AI (AIQ) 27.27 1.83% 2023-06-09 07:22:27
4 Bionano Genomics (BNGO) 0.74 1.77% 2023-06-09 07:28:31
5 PT Telekomunikasi (TLK) 28.58 1.31% 2023-06-09 04:21:19
6 HDFC Bank Limited (HDB) 65.47 1.22% 2023-06-09 07:19:15
7 Fox Corporation (FOX) 32.00 1.2% 2023-06-09 04:09:51
8 Inovio Pharmaceuticals (INO) 0.56 0.85% 2023-06-09 07:10:32
9 Box (BOX) 29.13 0.73% 2023-06-09 04:47:11
10 Gevo (GEVO) 1.59 0.63% 2023-06-09 07:24:50

The three biggest losers today are Nautilus, DISH Network, and Fresenius Medical Care AG.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Nautilus (NLS) 1.27 -3.05% 2023-06-09 04:42:45
2 DISH Network (DISH) 7.25 -2.42% 2023-06-09 07:23:53
3 Fresenius Medical Care AG (FMS) 22.78 -2.02% 2023-06-09 07:33:28
4 Momo (MOMO) 9.22 -1.5% 2023-06-09 07:11:14
5 Banco Santander (SAN) 3.44 -1.15% 2023-06-09 04:44:15
6 Amicus Therapeutics (FOLD) 12.48 -1.11% 2023-06-09 07:09:46
7 Gilead Sciences (GILD) 77.81 -0.75% 2023-06-09 07:24:53
8 Deutsche Bank (DB) 10.60 -0.75% 2023-06-09 07:32:44
9 Aurora Cannabis (ACB) 0.52 -0.63% 2023-06-09 04:46:53
10 Comcast Corporation (CMCSA) 40.24 -0.57% 2023-06-09 07:23:28

Premarket Winners today

1. Nikola (NKLA) – Premarket: 5.11%

Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions. It operates through two business units, Truck and Energy. The Truck business unit develops and commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. The Energy business unit develops and constructs a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. The company also assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.

NASDAQ ended the session with Nikola jumping 3% to $0.61 on Friday, after two successive sessions in a row of gains. NASDAQ rose 1.02% to $13,238.52, following the last session’s upward trend on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, Nikola has a trailing twelve months EPS of $-1.62.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -137.05%.

Sales Growth

Nikola’s sales growth is negative 16.8% for the ongoing quarter and 37.9% for the next.

Yearly Top and Bottom Value

Nikola’s stock is valued at $0.61 at 08:34 EST, way below its 52-week high of $8.97 and way above its 52-week low of $0.55.

More news about Nikola.

2. Citizens Financial Group (CFG) – Premarket: 1.87%

Citizens Financial Group, Inc. operates as the bank holding company for Citizens Bank, National Association that provides retail and commercial banking products and services to individuals, small businesses, middle-market companies, corporations, and institutions in the United States. The company operates in two segments, Consumer Banking and Commercial Banking. The Consumer Banking segment offers deposit products, mortgage and home equity lending products, credit cards, business loans, wealth management, and investment services; and auto, education, and point-of-sale finance loans, as well as digital deposit products. This segment serves its customers through telephone service centers, as well as through its online and mobile platforms. The Commercial Banking segment provides various financial products and solutions, including lending and leasing, deposit and treasury management services, foreign exchange, and interest rate and commodity risk management solutions, as well as syndicated loans, corporate finance, mergers and acquisitions, and debt and equity capital markets services. This segment serves government banking, not-for-profit, healthcare, technology, professionals, oil and gas, asset finance, franchise finance, asset-based lending, commercial real estate, private equity, and sponsor finance industries. The company was formerly known as RBS Citizens Financial Group, Inc. and changed its name to Citizens Financial Group, Inc. in April 2014. Citizens Financial Group, Inc. was founded in 1828 and is headquartered in Providence, Rhode Island.

NYSE ended the session with Citizens Financial Group falling 0.62% to $28.83 on Friday while NYSE jumped 0.21% to $15,502.64.

Earnings Per Share

As for profitability, Citizens Financial Group has a trailing twelve months EPS of $4.17.

PE Ratio

Citizens Financial Group has a trailing twelve months price to earnings ratio of 6.91. Meaning, the purchaser of the share is investing $6.91 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.35%.

Yearly Top and Bottom Value

Citizens Financial Group’s stock is valued at $28.83 at 08:34 EST, way under its 52-week high of $44.82 and way higher than its 52-week low of $23.37.

Volume

Today’s last reported volume for Citizens Financial Group is 5455320 which is 44.7% below its average volume of 9865700.

Moving Average

Citizens Financial Group’s value is under its 50-day moving average of $30.34 and way below its 200-day moving average of $37.09.

Volatility

Citizens Financial Group’s last week, last month’s, and last quarter’s current intraday variation average was 1.56%, 0.96%, and 2.68%.

Citizens Financial Group’s highest amplitude of average volatility was 2.24% (last week), 2.48% (last month), and 2.68% (last quarter).

More news about Citizens Financial Group.

3. Global X AI (AIQ) – Premarket: 1.83%

NASDAQ ended the session with Global X AI jumping 1.32% to $26.78 on Friday, following the last session’s upward trend. NASDAQ rose 1.02% to $13,238.52, following the last session’s upward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, Global X AI has a trailing twelve months EPS of $0.43.

PE Ratio

Global X AI has a trailing twelve months price to earnings ratio of 27.89. Meaning, the purchaser of the share is investing $27.89 for every dollar of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Global X AI’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for Global X AI is 231045 which is 77.85% above its average volume of 129906.

Volatility

Global X AI’s last week, last month’s, and last quarter’s current intraday variation average was 0.04%, 0.58%, and 1.04%.

Global X AI’s highest amplitude of average volatility was 0.96% (last week), 1.11% (last month), and 1.04% (last quarter).

More news about Global X AI.

4. Bionano Genomics (BNGO) – Premarket: 1.77%

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

NASDAQ ended the session with Bionano Genomics dropping 2.92% to $0.73 on Friday, after four successive sessions in a row of losses. NASDAQ jumped 1.02% to $13,238.52, following the last session’s upward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, Bionano Genomics has a trailing twelve months EPS of $-0.54.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -51.51%.

Yearly Top and Bottom Value

Bionano Genomics’s stock is valued at $0.73 at 08:34 EST, way below its 52-week high of $4.35 and way above its 52-week low of $0.60.

More news about Bionano Genomics.

5. PT Telekomunikasi (TLK) – Premarket: 1.31%

Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk provides information and communications technology, and telecommunications network services worldwide. The company operates through mobile, consumer, enterprise, Wholesale and International Business, and Other segments. The Mobile segment offers mobile voice, SMS, value added services, and mobile broadband services. The Consumer segment provides fixed wireline, pay TV, and internet services; and other telecommunication services to home customers. The Enterprise segment offers end-to-end solution to corporate and institutions. The Wholesale and International Business segment provides interconnection services, leased lines, satellite, very small aperture terminal, broadband access, information technology services, data, and internet services to other licensed operator companies and institutions. The Other segment offers digital content products, big data, business to business commerce, and financial services to individual and corporate customers. The company also engages in leasing of towers and other telecommunication services; provision of consultation service of hardware, computer software, and data center, as well as multimedia portal services; property development and management; trading service related to information and technology, multimedia, entertainment, and investment; and digital content exchange hub services. The company was founded in 1884 and is headquartered in Bandung, Indonesia.

NYSE ended the session with PT Telekomunikasi jumping 1.04% to $28.21 on Friday while NYSE rose 0.21% to $15,502.64.

Earnings Per Share

As for profitability, PT Telekomunikasi has a trailing twelve months EPS of $1.41.

PE Ratio

PT Telekomunikasi has a trailing twelve months price to earnings ratio of 20.01. Meaning, the purchaser of the share is investing $20.01 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.18%.

Volume

Today’s last reported volume for PT Telekomunikasi is 134559 which is 31.24% below its average volume of 195722.

Yearly Top and Bottom Value

PT Telekomunikasi’s stock is valued at $28.21 at 08:34 EST, way below its 52-week high of $31.95 and way above its 52-week low of $23.03.

Moving Average

PT Telekomunikasi’s value is higher than its 50-day moving average of $27.62 and above its 200-day moving average of $27.20.

More news about PT Telekomunikasi.

6. HDFC Bank Limited (HDB) – Premarket: 1.22%

HDFC Bank Limited provides banking and financial services to individuals and businesses in India, Bahrain, Hong Kong, and Dubai. It operates in Treasury, Retail Banking, Wholesale Banking, Other Banking Business, and Unallocated segments. The company accepts savings, salary, current, rural, public provident fund, pension, and Demat accounts; fixed and recurring deposits; and safe deposit lockers, as well as offshore accounts and deposits, overdrafts against fixed deposits, and sweep-in facilities. It also provides personal, home, car, two wheeler, business, educational, gold, consumer, and rural loans; loans against properties, securities, rental receivables, and assets; loans for professionals; government sponsored programs; and loans on credit card, as well as working capital and commercial/construction equipment finance, healthcare/medical equipment and commercial vehicle finance, dealer finance, and term and professional loans. The company offers credit, debit, prepaid, and forex cards; payment and collection, export, import, remittance, bank guarantee, letter of credit, trade, hedging, and merchant and cash management services; insurance and investment products. It provides short term finance, bill discounting, structured finance, export credit, loan syndication, and documents collection services; online and wholesale, mobile, and phone banking services; unified payment interface, immediate payment, national electronic funds transfer, and real time gross settlement services; and channel financing, vendor financing, reimbursement account, money market, derivatives, employee trusts, cash surplus corporates, tax payment, and bankers to rights/public issue services, as well as financial solutions for supply chain partners and agricultural customers. The company operates 6,378 branches and 18,620 automated teller machines in 3,203 cities/towns. The company was incorporated in 1994 and is based in Mumbai, India.

NYSE ended the session with HDFC Bank Limited dropping 0.33% to $64.68 on Friday, after two sequential sessions in a row of losses. NYSE jumped 0.21% to $15,502.64, after three sequential sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, HDFC Bank Limited has a trailing twelve months EPS of $2.52.

PE Ratio

HDFC Bank Limited has a trailing twelve months price to earnings ratio of 25.67. Meaning, the purchaser of the share is investing $25.67 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.15%.

Volume

Today’s last reported volume for HDFC Bank Limited is 577963 which is 64.92% below its average volume of 1647650.

Volatility

HDFC Bank Limited’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.30%, a negative 0.09%, and a positive 1.04%.

HDFC Bank Limited’s highest amplitude of average volatility was 0.77% (last week), 0.89% (last month), and 1.04% (last quarter).

More news about HDFC Bank Limited.

7. Fox Corporation (FOX) – Premarket: 1.2%

Fox Corporation operates as a news, sports, and entertainment company in the United States (U.S.). The company operates through Cable Network Programming; Television; and Other, Corporate and Eliminations segments. The Cable Network Programming segment produces and licenses news, business news, and sports content for distribution through traditional and virtual multi-channel video programming distributors (MVPDs) and other digital platforms, primarily in the U.S. It operates FOX News, a national cable news channel; FOX Business, a business news national cable channel; FS1 and FS2 multi-sport national networks; FOX Sports Racing, a video programming service that comprises motor sports programming; FOX Soccer Plus, a video programming network for live soccer and rugby competitions; FOX Deportes, a Spanish-language sports programming service; and Big Ten Network, a national video programming service. The Television segment acquires, produces, markets, and distributes programming. It operates The FOX Network, a national television broadcast network that broadcasts sports programming and entertainment; Tubi, an advertising-supported video-on-demand service; Fox Alternative Entertainment, a full-service production studio that develops and produces unscripted and alternative programming; MyNetworkTV, a programming distribution service; and Blockchain Creative Labs, which is focuses on the creation, distribution and monetization of Web3 content. This segment owns and operates 29 broadcast television stations. The Other, Corporate and Eliminations segment owns the FOX Studios Lot that provides production and post-production services, including 15 sound stages, two broadcast studios, theaters and screening rooms, editing rooms, and other television and film production facilities in Los Angeles, California. The company was incorporated in 2018 and is based in New York, New York.

NASDAQ ended the session with Fox Corporation rising 1.43% to $31.62 on Friday, after five sequential sessions in a row of gains. NASDAQ jumped 1.02% to $13,238.52, following the last session’s upward trend on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, Fox Corporation has a trailing twelve months EPS of $2.16.

PE Ratio

Fox Corporation has a trailing twelve months price to earnings ratio of 14.64. Meaning, the purchaser of the share is investing $14.64 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.91%.

More news about Fox Corporation.

8. Inovio Pharmaceuticals (INO) – Premarket: 0.85%

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

NASDAQ ended the session with Inovio Pharmaceuticals falling 5.02% to $0.55 on Friday, following the last session’s downward trend. NASDAQ jumped 1.02% to $13,238.52, following the last session’s upward trend on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-1.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -87.1%.

More news about Inovio Pharmaceuticals.

9. Box (BOX) – Premarket: 0.73%

Box, Inc. provides a cloud content management platform that enables organizations of various sizes to manage and share their content from anywhere on any device. The company's Software-as-a-Service platform enables users to collaborate on content internally and with external parties, automate content-driven business processes, develop custom applications, and implement data protection, security, and compliance features to comply with legal and regulatory requirements, internal policies, and industry standards and regulations. It also offers web, mobile, and desktop applications for cloud content management on a platform for developing custom applications, as well as industry-specific capabilities. As of January 31, 2023, the company had approximately 100,000 paying organizations, and its solution was offered in 25 languages. It serves financial services, health care, government, and legal services industries in the United States and internationally. The company was formerly known as Box.net, Inc. and changed its name to Box, Inc. in November 2011. Box, Inc. was incorporated in 2005 and is headquartered in San Francisco Bay Area, California.

NYSE ended the session with Box jumping 0.75% to $28.92 on Friday while NYSE rose 0.21% to $15,502.64.

Earnings Per Share

As for profitability, Box has a trailing twelve months EPS of $0.14.

PE Ratio

Box has a trailing twelve months price to earnings ratio of 206.61. Meaning, the purchaser of the share is investing $206.61 for every dollar of annual earnings.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 17.4% and 17.9%, respectively.

Sales Growth

Box’s sales growth is 4.5% for the present quarter and 5.8% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Box’s stock is considered to be overbought (>=80).

More news about Box.

10. Gevo (GEVO) – Premarket: 0.63%

Gevo, Inc. operates as a renewable fuels company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company offers renewable gasoline and diesel, isooctane, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.

NASDAQ ended the session with Gevo dropping 1.56% to $1.58 on Friday while NASDAQ jumped 1.02% to $13,238.52.

Earnings Per Share

As for profitability, Gevo has a trailing twelve months EPS of $-0.44.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.72%.

More news about Gevo.

Premarket Losers Today

1. Nautilus (NLS) – Premarket: -3.05%

Nautilus, Inc., a fitness solutions company, designs, develops, sources, and markets cardio and strength fitness products, and related accessories for consumer and commercial use in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company operates in two segments, Direct and Retail. It offers specialized cardio products, treadmills, ellipticals, bike products, home gyms, dumbbells, barbells, and kettlebells primarily under the Nautilus, Bowflex, Octane Fitness, and Schwinn brands, as well as fitness digital platform under the JRNY brand. In addition, it engages in licensing its brands and intellectual properties. The company offers its products directly to consumers through television advertising, social media, websites, and catalogs; and through a network of retail companies consisting of sporting goods stores, online retailers, electronics stores, furniture stores, and large-format and warehouse stores, as well as specialty retailers and independent bike dealers. Nautilus, Inc. was founded in 1986 and is headquartered in Vancouver, Washington.

NYSE ended the session with Nautilus rising 0.38% to $1.31 on Friday, following the last session’s upward trend. NYSE rose 0.21% to $15,502.64, after three consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Nautilus has a trailing twelve months EPS of $-3.4.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -95.4%.

Volume

Today’s last reported volume for Nautilus is 58720 which is 65.58% below its average volume of 170611.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 77.6% and 26.8%, respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nautilus’s stock is considered to be oversold (<=20).

More news about Nautilus.

2. DISH Network (DISH) – Premarket: -2.42%

DISH Network Corporation, together with its subsidiaries, provides pay-TV services in the United States. The company operates in two segments, Pay-TV and Wireless. It offers video services under the DISH TV brand; and programming packages that include programming through national broadcast networks, local broadcast networks, and national and regional cable networks, as well as regional and specialty sports channels, premium movie channels, and Latino and international programming packages. The company also provides access to movies and television shows through TV or Internet-connected devices; and dishanywhere.com and mobile applications on Internet-connected devices to view authorized content, search program listings, and remotely control certain features of their DVRs. In addition, it offers Sling TV services, including Sling domestic, Sling International, Sling Latino, Sling Orange, and Sling Blue services that require an internet connection and are available on streaming-capable devices, such as streaming media devices, TVs, tablets, computers, game consoles, and phones, as well as market SLING TV services to consumers who do not subscribe to traditional satellite and cable pay-TV services. Further, the company provides wireless subscribers consumer plans with no annual service contracts, as well as monthly service plans, including high-speed data and unlimited talk and text. The company offers receiver systems and programming through direct sales channels, as well as independent third parties, such as small retailers, direct marketing groups, local and regional consumer electronics stores, retailers, and telecommunications companies. DISH Network Corporation was founded in 1980 and is headquartered in Englewood, Colorado.

NASDAQ ended the session with DISH Network sliding 4.56% to $7.43 on Friday, following the last session’s downward trend. NASDAQ rose 1.02% to $13,238.52, following the last session’s upward trend on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, DISH Network has a trailing twelve months EPS of $3.48.

PE Ratio

DISH Network has a trailing twelve months price to earnings ratio of 2.13. Meaning, the purchaser of the share is investing $2.13 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.36%.

Sales Growth

DISH Network’s sales growth is negative 6.7% for the current quarter and negative 6.4% for the next.

Volume

Today’s last reported volume for DISH Network is 8059090 which is 25.7% below its average volume of 10846800.

More news about DISH Network.

3. Fresenius Medical Care AG (FMS) – Premarket: -2.02%

Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

NYSE ended the session with Fresenius Medical Care AG jumping 2.04% to $23.25 on Friday, after five sequential sessions in a row of gains. NYSE rose 0.21% to $15,502.64, after three sequential sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Fresenius Medical Care AG has a trailing twelve months EPS of $1.12.

PE Ratio

Fresenius Medical Care AG has a trailing twelve months price to earnings ratio of 20.75. Meaning, the purchaser of the share is investing $20.75 for every dollar of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Fresenius Medical Care AG’s stock is considered to be oversold (<=20).

Moving Average

Fresenius Medical Care AG’s value is above its 50-day moving average of $21.67 and way higher than its 200-day moving average of $17.87.

Volume

Today’s last reported volume for Fresenius Medical Care AG is 491134 which is 33.31% below its average volume of 736498.

More news about Fresenius Medical Care AG.

4. Momo (MOMO) – Premarket: -1.5%

Hello Group Inc. provides mobile-based social and entertainment services in the People's Republic of China. The company offers Momo, a mobile application that connects people and facilitates social interactions based on location, interests, and various online recreational activities including, live talent shows, short videos, social games, as well as other video- and audio-based interactive experiences, such as online parties, mobile karaoke and user participated reality shows; Tantan, a social and dating application; and other applications under the Hertz, Soulchill, Duidui, and Tietie names. The company also provides livestream services for various content and activities comprising talent shows, such as singing, dancing, and talk shows, as well as casual chatting, and other forms of interactions between broadcasters and viewers to its platform's users; value-added services; advertising and marketing services; and mobile games. The company was formerly known as Momo Inc. and changed its name to Hello Group Inc. in August 2021. Hello Group Inc. was incorporated in 2011 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with Momo rising 3.77% to $9.36 on Friday while NASDAQ rose 1.02% to $13,238.52.

Earnings Per Share

As for profitability, Momo has a trailing twelve months EPS of $1.01.

PE Ratio

Momo has a trailing twelve months price to earnings ratio of 9.27. Meaning, the purchaser of the share is investing $9.27 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.76%.

Moving Average

Momo’s worth is above its 50-day moving average of $8.54 and way above its 200-day moving average of $7.44.

More news about Momo.

5. Banco Santander (SAN) – Premarket: -1.15%

Banco Santander, S.A. provides various retail and commercial banking products and services to individuals, small and medium-sized enterprises, and large companies worldwide. The company operates through Retail Banking, Santander Corporate & Investment Banking, Wealth Management & Insurance, and PagoNxt segments. It offers demand and time deposits, and current and savings accounts; mortgages, consumer finance, syndicated corporate loans, cash management, export and agency finance, trade and working capital solutions, and corporate finance; and insurance products. The company also provides cash, asset, and wealth management; and private banking services. In addition, it is involved in the corporate banking, treasury, risk hedging, foreign trade, and investment banking activities, as well as provides digital payment solutions. The company was formerly known as Banco Santander Central Hispano S.A. and changed its name to Banco Santander, S.A. in June 2007. Banco Santander, S.A. was founded in 1856 and is headquartered in Madrid, Spain.

NYSE ended the session with Banco Santander rising 1.12% to $3.48 on Friday while NYSE rose 0.21% to $15,502.64.

Earnings Per Share

As for profitability, Banco Santander has a trailing twelve months EPS of $0.61.

PE Ratio

Banco Santander has a trailing twelve months price to earnings ratio of 5.7. Meaning, the purchaser of the share is investing $5.7 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.82%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Apr 26, 2023, the estimated forward annual dividend rate is 0.12 and the estimated forward annual dividend yield is 3.65%.

Moving Average

Banco Santander’s value is below its 50-day moving average of $3.56 and way above its 200-day moving average of $3.12.

Volatility

Banco Santander’s last week, last month’s, and last quarter’s current intraday variation average was 0.30%, 0.09%, and 2.22%.

Banco Santander’s highest amplitude of average volatility was 0.89% (last week), 1.69% (last month), and 2.22% (last quarter).

Volume

Today’s last reported volume for Banco Santander is 2562920 which is 41.11% below its average volume of 4352150.

More news about Banco Santander.

6. Amicus Therapeutics (FOLD) – Premarket: -1.11%

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. The company also develops AT-GAA, a novel treatment paradigm for Pompe disease; and enzyme replacement therapies for Pompe diseases. It has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. The company was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.

NASDAQ ended the session with Amicus Therapeutics jumping 0.2% to $12.62 on Friday while NASDAQ rose 1.02% to $13,238.52.

Earnings Per Share

As for profitability, Amicus Therapeutics has a trailing twelve months EPS of $-0.71.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -119.72%.

More news about Amicus Therapeutics.

7. Gilead Sciences (GILD) – Premarket: -0.75%

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

NASDAQ ended the session with Gilead Sciences rising 3.06% to $78.40 on Friday while NASDAQ rose 1.02% to $13,238.52.

Earnings Per Share

As for profitability, Gilead Sciences has a trailing twelve months EPS of $4.52.

PE Ratio

Gilead Sciences has a trailing twelve months price to earnings ratio of 17.35. Meaning, the purchaser of the share is investing $17.35 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.11%.

Moving Average

Gilead Sciences’s worth is under its 50-day moving average of $80.77 and above its 200-day moving average of $78.25.

Yearly Top and Bottom Value

Gilead Sciences’s stock is valued at $78.40 at 08:34 EST, way below its 52-week high of $89.74 and way higher than its 52-week low of $57.17.

Sales Growth

Gilead Sciences’s sales growth is 3.5% for the current quarter and 11.3% for the next.

More news about Gilead Sciences.

8. Deutsche Bank (DB) – Premarket: -0.75%

Deutsche Bank Aktiengesellschaft, operates as a stock corporation, engages in the provision of corporate and investment banking, and asset management products and services to private clients, corporate entities, and institutional clients worldwide. Its Corporate Bank segment provides cash management, trade finance and lending, trust and agency, foreign exchange, and securities services, as well as risk management solutions. The company's Investment Bank segment offers debt origination, merger and acquisitions, and equity advisory services. Its Private Bank segment provides payment and account services, and credit and deposit products, as well as investment advice products, such as environmental, social, and governance products. This segment also provides banking, wealth management services, postal and parcel services; and offers support in planning, managing and investing wealth, financing personal and business interests, and servicing institutional and corporate needs. The company's Asset Management segment provides investment solutions, such as alternative investments, which include real estate, infrastructure, private equity, liquid real assets, and sustainable investments; and various other services, including insurance and pension solutions, asset liability management, portfolio management solutions, and asset allocation advisory to individuals and institutions. Deutsche Bank Aktiengesellschaft was founded in 1870 and is based in Frankfurt am Main, Germany.

NYSE ended the session with Deutsche Bank jumping 1.23% to $10.68 on Friday while NYSE rose 0.21% to $15,502.64.

Earnings Per Share

As for profitability, Deutsche Bank has a trailing twelve months EPS of $2.72.

PE Ratio

Deutsche Bank has a trailing twelve months price to earnings ratio of 3.93. Meaning, the purchaser of the share is investing $3.93 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.1%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on May 17, 2023, the estimated forward annual dividend rate is 0.33 and the estimated forward annual dividend yield is 3.13%.

Yearly Top and Bottom Value

Deutsche Bank’s stock is valued at $10.68 at 08:34 EST, way below its 52-week high of $13.57 and way higher than its 52-week low of $7.25.

Revenue Growth

Year-on-year quarterly revenue growth grew by 3.9%, now sitting on 26.26B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Deutsche Bank’s stock is considered to be oversold (<=20).

Previous days news about Deutsche Bank

  • Deutsche bank (db) stock moves -0.19%: what you should know. According to Zacks on Wednesday, 7 June, "In the latest trading session, Deutsche Bank (DB Quick QuoteDB – Free Report) closed at $10.55, marking a -0.19% move from the previous day. ", "Wall Street will be looking for positivity from Deutsche Bank as it approaches its next earnings report date. "

More news about Deutsche Bank.

9. Aurora Cannabis (ACB) – Premarket: -0.63%

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, Caribbeans, South America, and Israel; and distribution and sale of hemp-derived cannabidiol (CBD) products in the United States (U.S.) market. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, and cannabis extracts, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried milled strains and strain specific cannabis oils. Further, it offers patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

NYSE ended the session with Aurora Cannabis falling 2.13% to $0.52 on Friday while NYSE rose 0.21% to $15,502.64.

Earnings Per Share

As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-6.24.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Aurora Cannabis’s stock is considered to be oversold (<=20).

Sales Growth

Aurora Cannabis’s sales growth is 27.5% for the present quarter and 26.6% for the next.

More news about Aurora Cannabis.

10. Comcast Corporation (CMCSA) – Premarket: -0.57%

Comcast Corporation operates as a media and technology company worldwide. It operates through Residential Connectivity & Platforms, Business Services Connectivity, Media, Studios, and Theme Parks segments. The Residential Connectivity & Platforms segment provides residential broadband and wireless connectivity services, residential and business video services, advertising sales, and Sky channels. The Business Services Connectivity segment offers connectivity services for small business locations, which include broadband, voice, and wireless services, as well as solutions for medium-sized customers and larger enterprises; and small business connectivity services for international locations. The Media segment operates NBCUniversal's television and streaming business, including national and regional cable networks; the NBC and Telemundo broadcast networks; NBC and Telemundo owned local broadcast television stations; and Peacock, a direct-to-consumer streaming service. It also operates international networks comprising the Sky Sports channels, as well as other digital properties. The Studios segment operates NBCUniversal and Sky film and television studio production and distribution operations. The Theme Parks segment operates Universal theme parks in Orlando, Florida; Hollywood, California; Osaka, Japan; and Beijing, China. The company also owns the Philadelphia Flyers and the Wells Fargo Center arena in Philadelphia, Pennsylvania; and operates Xumo, a consolidated streaming platform. Comcast Corporation was founded in 1963 and is headquartered in Philadelphia, Pennsylvania.

NASDAQ ended the session with Comcast Corporation jumping 0.29% to $40.47 on Friday while NASDAQ jumped 1.02% to $13,238.52.

Earnings Per Share

As for profitability, Comcast Corporation has a trailing twelve months EPS of $1.34.

PE Ratio

Comcast Corporation has a trailing twelve months price to earnings ratio of 30.2. Meaning, the purchaser of the share is investing $30.2 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.8%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Comcast Corporation’s stock is considered to be oversold (<=20).

More news about Comcast Corporation.

Stay up to date with our premarket winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *